Tarus Therapeutics
Tarus is a biotech company focused on nucleotide metabolism in cancer. The company’s lead programs target the immunosuppressive adenosine pathway in the tumour microenvironment for the treatment of resistant cancers.
Morgan Prestwich were retained to appoint their first board members:
- 2 x Non-Executive Director